Management of Hodgkin Lymphoma in a Sickle Cell Patient: A Case Report

Farah Ashraf, Pragnan Kancharla, Mendel Goldfinger

Research output: Contribution to journalArticle

Abstract

Sickle cell disease (SCD) is an inherited disorder of hemoglobin mutation in red blood cells, with a patient population that is increasing in age in recent decades due to advances in modern medicine. Hodgkin's lymphoma (HL) is a cancer of white blood cells, and while concomitance of SCD and Hodgkin's has been reported, a discussion of treatment for HL in SCD is lacking from the literature. We present a case of effectively treated HL in SCD and put forth that the regimen used is a practical choice, and as it was completed fully as outpatient, it improved the patient's quality of life compared to an inpatient regimen.

Original languageEnglish (US)
Pages (from-to)224-227
Number of pages4
JournalCase Reports in Oncology
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Hodgkin Disease
Drug Therapy
Modern 1601-history
Inpatients
Hemoglobins
Leukocytes
Outpatients
Erythrocytes
Quality of Life
Mutation
Population
Neoplasms
Therapeutics

Keywords

  • Chemotherapy
  • Hodgkin lymphoma
  • Sickle cell disease

ASJC Scopus subject areas

  • Oncology

Cite this

Management of Hodgkin Lymphoma in a Sickle Cell Patient : A Case Report. / Ashraf, Farah; Kancharla, Pragnan; Goldfinger, Mendel.

In: Case Reports in Oncology, Vol. 12, No. 1, 01.01.2019, p. 224-227.

Research output: Contribution to journalArticle

Ashraf, Farah ; Kancharla, Pragnan ; Goldfinger, Mendel. / Management of Hodgkin Lymphoma in a Sickle Cell Patient : A Case Report. In: Case Reports in Oncology. 2019 ; Vol. 12, No. 1. pp. 224-227.
@article{7153e0a1c7c14766969c7b8d4d17879b,
title = "Management of Hodgkin Lymphoma in a Sickle Cell Patient: A Case Report",
abstract = "Sickle cell disease (SCD) is an inherited disorder of hemoglobin mutation in red blood cells, with a patient population that is increasing in age in recent decades due to advances in modern medicine. Hodgkin's lymphoma (HL) is a cancer of white blood cells, and while concomitance of SCD and Hodgkin's has been reported, a discussion of treatment for HL in SCD is lacking from the literature. We present a case of effectively treated HL in SCD and put forth that the regimen used is a practical choice, and as it was completed fully as outpatient, it improved the patient's quality of life compared to an inpatient regimen.",
keywords = "Chemotherapy, Hodgkin lymphoma, Sickle cell disease",
author = "Farah Ashraf and Pragnan Kancharla and Mendel Goldfinger",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000497480",
language = "English (US)",
volume = "12",
pages = "224--227",
journal = "Case Reports in Oncology",
issn = "1662-6575",
number = "1",

}

TY - JOUR

T1 - Management of Hodgkin Lymphoma in a Sickle Cell Patient

T2 - A Case Report

AU - Ashraf, Farah

AU - Kancharla, Pragnan

AU - Goldfinger, Mendel

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Sickle cell disease (SCD) is an inherited disorder of hemoglobin mutation in red blood cells, with a patient population that is increasing in age in recent decades due to advances in modern medicine. Hodgkin's lymphoma (HL) is a cancer of white blood cells, and while concomitance of SCD and Hodgkin's has been reported, a discussion of treatment for HL in SCD is lacking from the literature. We present a case of effectively treated HL in SCD and put forth that the regimen used is a practical choice, and as it was completed fully as outpatient, it improved the patient's quality of life compared to an inpatient regimen.

AB - Sickle cell disease (SCD) is an inherited disorder of hemoglobin mutation in red blood cells, with a patient population that is increasing in age in recent decades due to advances in modern medicine. Hodgkin's lymphoma (HL) is a cancer of white blood cells, and while concomitance of SCD and Hodgkin's has been reported, a discussion of treatment for HL in SCD is lacking from the literature. We present a case of effectively treated HL in SCD and put forth that the regimen used is a practical choice, and as it was completed fully as outpatient, it improved the patient's quality of life compared to an inpatient regimen.

KW - Chemotherapy

KW - Hodgkin lymphoma

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=85062718180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062718180&partnerID=8YFLogxK

U2 - 10.1159/000497480

DO - 10.1159/000497480

M3 - Article

AN - SCOPUS:85062718180

VL - 12

SP - 224

EP - 227

JO - Case Reports in Oncology

JF - Case Reports in Oncology

SN - 1662-6575

IS - 1

ER -